Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari L Ring

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologistsAnne M Mills, Tim N Bullock, Kari L Ring
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 9, 2020
LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for ImmunotherapyLisa A Friedman, Kari L Ring, Anne M Mills
Clinical Obstetrics and Gynecology|September 26, 2024
What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes ( ATM , BRIP1 , RAD51C , RAD51D , and PALB2 )Ester I Goldfeld, Brianna E Kelly, Kari L Ring
Obstetrics and Gynecology|November 11, 2022
Endometrial HyperplasiaKari L Ring, Anne M Mills, Susan C Modesitt
Journal of the American Society of Cytopathology|September 6, 2024
Cervical cytology in endometrial cancer patients with Lynch syndrome: opportunities for early detection and limitationsYongsang Park, Megan E Dibbern, Kari L Ring, et al.
American Journal of Obstetrics and Gynecology|April 16, 2017
Current and future role of genetic screening in gynecologic malignanciesKari L Ring, Christine Garcia, Martha H Thomas, et al.
Gynecologic Oncology|January 10, 2017
Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumorsChelsea E Gottlieb, Anne M Mills, Janet V Cross, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 22, 2018
Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomasAnne Mills, Sara Zadeh, Emily Sloan, et al.
The American Journal of Surgical Pathology|May 30, 2023
Somatic Sequencing and Microsatellite Instability Results From Mismatch Repair-deficient Endometrial Carcinoma Patients Without Lynch Syndrome ("Lynch-like" tumors): Implications for Heritable Cancer Screening, Molecular Prognostication, and Immunotherapeutic VulnerabilityNgome L Makia, Martha Thomas, Kari L Ring, et al.
The American Journal of Surgical Pathology|December 17, 2016
PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated TumorsEmily A Sloan, Kari L Ring, Brian C Willis, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologistsAnne M Mills, Tim N Bullock, Kari L Ring
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 9, 2020
LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for ImmunotherapyLisa A Friedman, Kari L Ring, Anne M Mills
Clinical Obstetrics and Gynecology|September 26, 2024
What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes ( ATM , BRIP1 , RAD51C , RAD51D , and PALB2 )Ester I Goldfeld, Brianna E Kelly, Kari L Ring
Obstetrics and Gynecology|November 11, 2022
Endometrial HyperplasiaKari L Ring, Anne M Mills, Susan C Modesitt
Journal of the American Society of Cytopathology|September 6, 2024
Cervical cytology in endometrial cancer patients with Lynch syndrome: opportunities for early detection and limitationsYongsang Park, Megan E Dibbern, Kari L Ring, et al.
American Journal of Obstetrics and Gynecology|April 16, 2017
Current and future role of genetic screening in gynecologic malignanciesKari L Ring, Christine Garcia, Martha H Thomas, et al.
Gynecologic Oncology|January 10, 2017
Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumorsChelsea E Gottlieb, Anne M Mills, Janet V Cross, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 22, 2018
Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomasAnne Mills, Sara Zadeh, Emily Sloan, et al.
The American Journal of Surgical Pathology|May 30, 2023
Somatic Sequencing and Microsatellite Instability Results From Mismatch Repair-deficient Endometrial Carcinoma Patients Without Lynch Syndrome ("Lynch-like" tumors): Implications for Heritable Cancer Screening, Molecular Prognostication, and Immunotherapeutic VulnerabilityNgome L Makia, Martha Thomas, Kari L Ring, et al.
The American Journal of Surgical Pathology|December 17, 2016
PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated TumorsEmily A Sloan, Kari L Ring, Brian C Willis, et al.
Pageof 6